Hot Features
CERo Therapeutics Holdings, Inc., an immunotherapy company, engages in the development of engineered T cell therapeutics for the treatment of cancer. The company’s lead development candidate is CER-1236, an autologous T cell therapy candidate for the treatment of hematologic malignancies and solid t... CERo Therapeutics Holdings, Inc., an immunotherapy company, engages in the development of engineered T cell therapeutics for the treatment of cancer. The company’s lead development candidate is CER-1236, an autologous T cell therapy candidate for the treatment of hematologic malignancies and solid tumors. The company was incorporated in 2021 and is based in South San Francisco, California. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.0119 | -49.5833333333 | 0.024 | 0.024 | 0.0101 | 1709926 | 0.01409924 | CS |
| 4 | -0.0219 | -64.4117647059 | 0.034 | 0.034 | 0.0101 | 941380 | 0.01838232 | CS |
| 12 | -0.0229 | -65.4285714286 | 0.035 | 0.0399 | 0.0101 | 639955 | 0.0258292 | CS |
| 26 | -0.1076 | -89.8913951546 | 0.1197 | 0.1295 | 0.0101 | 571049 | 0.03686539 | CS |
| 52 | -0.0579 | -82.7142857143 | 0.07 | 0.2089 | 0.0101 | 708351 | 0.05533788 | CS |
| 156 | -0.0579 | -82.7142857143 | 0.07 | 0.2089 | 0.0101 | 708351 | 0.05533788 | CS |
| 260 | -0.0579 | -82.7142857143 | 0.07 | 0.2089 | 0.0101 | 708351 | 0.05533788 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.